In the present study, we used a three-marker fluorescence in situ hybridization (FISH) panel to detect TMPRSS2 and/or ERG rearrangements, AR gene amplification, and PTEN deletion in both primary and CRPC prostate cancer samples and compared the prevalence, concurrence, and interaction of these three markers. This evidence concerns the gene TMPRSS2 and prostate cancer.